Gockel I, Vetter G, Heintz A, Junginger Th
Department of General and Abdominal Surgery, Johannes Gutenberg University, Langenbeckstrasse 1, D-55101 Mainz, Germany.
Surg Endosc. 2005 Aug;19(8):1086-92. doi: 10.1007/s00464-004-2141-3. Epub 2005 May 26.
Due to the intraoperative catecholamine secretion with hemodynamic changes, a larger tumor size and marked neovascularization, as compared with other adrenal pathologies, endoscopic adrenalectomy for pheochromocytoma represents a particular challenge involving a more difficult and morbid procedure. The aim of this study was to identify the optimal surgical approach for endoscopic adrenalectomy in patients with pheochromocytoma.
Over a period of 10 years (February 1994 to June 2004), 38 consecutive patients underwent endoscopic adrenalectomy for pheochromocytoma. As three patients underwent a bilateral procedure, a total of 41 adrenalectomies were performed. The transperitoneal approach was carried out in 23 patients, whereas 18 patients underwent a retroperitoneal adrenalectomy by a single operative team. Perioperative parameters were prospectively followed.
There was no conversion to the open procedure. Intraoperative hypertensive episodes occurred in 21 patients (55.3%) and were controlled by antihypertensive agents. In 11 patients (28.9%), blood pressure values rose to above 200 mmHg (> 1 min). A comparison between the retroperitoneal and transperitoneal procedures did not show a significant difference between the maximum intraoperative systolic (p = 0.730) and diastolic (p = 0.663) blood pressure values although intraoperative blood pressure peaks were seen more frequently during retroperitoneal adrenalectomy. The operative time was shorter for the patients who had transperitoneal adrenalectomy than compared to for those who had retroperitoneal adrenalectomy, although the difference was not significant. The intraoperative blood loss, perioperative morbidity, and length of postoperative hospital stay did not differ significantly between the surgical techniques (p > 0.05).
After adequate preparation, endoscopic adrenalectomy may be performed in patients with pheochromocytoma via both the retroperitoneal and the transperitoneal approaches. The shorter operating time, less frequent intraoperative blood pressure peaks, and the better overview of the operating field recommend the transperitoneal approach with the patient placed in a lateral position as the preferred operative procedure.
与其他肾上腺疾病相比,由于嗜铬细胞瘤术中儿茶酚胺分泌伴血流动力学改变、肿瘤体积较大及显著的新生血管形成,嗜铬细胞瘤的内镜肾上腺切除术是一项特殊挑战,手术难度更大且并发症更多。本研究的目的是确定嗜铬细胞瘤患者内镜肾上腺切除术的最佳手术入路。
在10年期间(1994年2月至2004年6月),38例连续患者接受了嗜铬细胞瘤的内镜肾上腺切除术。由于3例患者接受了双侧手术,共进行了41例肾上腺切除术。23例患者采用经腹入路,而18例患者由同一手术团队进行了后腹腔镜肾上腺切除术。前瞻性记录围手术期参数。
无一例转为开放手术。21例患者(55.3%)术中出现高血压发作,通过使用抗高血压药物得到控制。11例患者(28.9%)血压值升至200 mmHg以上(>1分钟)。后腹腔镜和经腹手术之间的比较显示,术中最高收缩压(p = 0.730)和舒张压(p = 0.663)值无显著差异,尽管后腹腔镜肾上腺切除术期间术中血压峰值出现得更频繁。经腹肾上腺切除术患者的手术时间比后腹腔镜肾上腺切除术患者短,尽管差异不显著。两种手术技术在术中失血量、围手术期发病率和术后住院时间方面无显著差异(p > 0.05)。
经过充分准备,嗜铬细胞瘤患者可通过后腹腔镜和经腹入路进行内镜肾上腺切除术。手术时间较短、术中血压峰值出现频率较低以及手术视野更好,推荐将患者置于侧卧位的经腹入路作为首选手术方式。